Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (1): 64-70.doi: 10.19982/j.issn.1000-6621.20210545
• Original Articles • Previous Articles Next Articles
ZHANG Yang-ting1, LU Xue-zhao2, LI Xiao-na1, ZHONG Zhao-yi1, WANG Na3, CAI Jing1, MA Ai-guo1, LIU Yu-feng3(), WANG Qiu-zhen1(
)
Received:
2021-09-13
Online:
2022-01-10
Published:
2021-12-29
Contact:
LIU Yu-feng,WANG Qiu-zhen
E-mail:liuyufengqd@126.com;kevin_1971@126.com
Supported by:
CLC Number:
ZHANG Yang-ting, LU Xue-zhao, LI Xiao-na, ZHONG Zhao-yi, WANG Na, CAI Jing, MA Ai-guo, LIU Yu-feng, WANG Qiu-zhen. Study on influencing factors of anti-tuberculosis drug-induced liver injury in pulmonary tuberculosis patients complicated with diabetes mellitus[J]. Chinese Journal of Antituberculosis, 2022, 44(1): 64-70. doi: 10.19982/j.issn.1000-6621.20210545
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20210545
基本特征 | 肝损伤组(53例) | 无肝损伤组(405例) | χ2值 | P值 |
---|---|---|---|---|
年龄(岁) | 0.238 | 0.626 | ||
≥60 | 15(28.3) | 128(31.6) | ||
<60 | 38(71.7) | 277(68.4) | ||
性别 | 1.194 | 0.274 | ||
男性 | 43(81.1) | 351(86.7) | ||
女性 | 10(18.9) | 54(13.3) | ||
婚姻状况 | 0.164 | 0.686 | ||
已婚 | 45(84.9) | 352(86.9) | ||
未婚/离异/丧偶 | 8(15.1) | 53(13.1) | ||
文化水平 | 3.535 | 0.316 | ||
小学及以下 | 17(32.1) | 97(23.9) | ||
初中 | 17(32.1) | 143(35.3) | ||
高中/职专 | 9(17.0) | 106(26.2) | ||
大专/职大及以上 | 10(18.8) | 59(14.6) | ||
职业 | 2.065 | 0.559 | ||
家务/待业/退休 | 12(22.6) | 124(30.6) | ||
农民 | 6(11.4) | 36(8.9) | ||
工人 | 15(28.3) | 90(22.2) | ||
其他a | 20(37.7) | 155(38.3) | ||
吸烟 | 4.422 | 0.035 | ||
是 | 31(58.5) | 175(43.2) | ||
否 | 22(41.5) | 230(56.8) | ||
基本特征 | 肝损伤组(53例) | 无肝损伤组(405例) | χ2值 | P值 |
饮酒 | 5.486 | 0.019 | ||
是 | 33(62.3) | 183(45.2) | ||
否 | 20(37.7) | 222(54.8) | ||
体力活动水平 | 10.832 | 0.004 | ||
轻度 | 38(71.7) | 276(68.2) | ||
中等 | 9(17.0) | 117(28.9) | ||
重度 | 6(11.3) | 12(2.9) | ||
体质量指数 | 12.659 | 0.005 | ||
<18.5 | 13(24.5) | 35(8.6) | ||
18.5~ | 25(47.2) | 225(55.6) | ||
24.0~ | 12(22.6) | 118(29.1) | ||
≥28.0 | 3(5.7) | 27(6.7) | ||
痰涂片 | 5.886 | 0.208 | ||
阴性 | 16(30.2) | 114(28.1) | ||
+ | 8(15.1) | 75(18.5) | ||
2(3.8) | 46(11.4) | |||
+ | 3(5.7) | 38(9.4) | ||
24(45.2) | 132(32.6) | |||
患者类型 | 1.011 | 0.315 | ||
复治 | 12(22.6) | 69(17.0) | ||
初治 | 41(77.4) | 336(83.0) | ||
使用保肝药 | 0.002 | 0.969 | ||
是 | 42(79.2) | 320(79.0) | ||
否 | 11(20.8) | 85(21.0) | ||
保肝药使用种类 | 1.701 | 0.427 | ||
0种 | 11(20.8) | 85(21.0) | ||
1~2种 | 28(52.8) | 243(60.0) | ||
3种及以上 | 14(26.4) | 77(19.0) |
临床指标 | 肝损伤组(53例) | 无肝损伤组(405例) | 统计检验值 | P值 |
---|---|---|---|---|
结核病特征性表现[例(发生率,%)] | ||||
咳嗽 | 48(90.6) | 365(90.6) | χ2=0.000 | 1.000 |
咳痰 | 45(84.9) | 325(80.6) | χ2=0.556 | 0.456 |
咯血 | 8(15.1) | 53(13.2) | χ2=0.153 | 0.696 |
发热 | 19(35.8) | 141(35.0) | χ2=0.015 | 0.902 |
乏力 | 22(41.5) | 177(43.9) | χ2=0.111 | 0.739 |
盗汗 | 17(32.1) | 120(29.8) | χ2=0.118 | 0.731 |
胸痛 | 12(22.6) | 69(17.1) | χ2=0.977 | 0.323 |
食欲减退 | 10(18.9) | 51(12.7) | χ2=1.560 | 0.212 |
胸闷 | 22(41.5) | 184(45.7) | χ2=0.325 | 0.568 |
血脂异常[例(发生率,%)] | ||||
高甘油三酯血症 | 3(5.7) | 28(6.9) | χ2=0.117 | 0.733 |
高胆固醇血症 | 1(1.9) | 21(5.2) | χ2=1.115 | 0.291 |
混合型高脂血症 | 3(5.7) | 9(2.2) | χ2=2.171 | 0.141 |
低高密度脂蛋白血症 | 24(45.3) | 115(28.4) | χ2=6.323 | 0.012 |
总蛋白(g/L, | 66.00±7.69 | 66.71±7.25 | t=0.454 | 0.524 |
白蛋白(g/L, | 36.81±5.45 | 39.78±12.39 | t=3.144 | 0.099 |
低蛋白血症[例(发生率,%)] | 6(11.3) | 25(6.2) | χ2=1.968 | 0.161 |
贫血[例(发生率,%)] | 20(37.7) | 85(21.0) | χ2=7.440 | 0.006 |
空腹血糖a(mmol/L, | 12.36±4.67 | 9.45±3.52 | t=-4.184 | <0.001 |
血糖控制不良a[例(发生率,%)] | 40(83.3) | 260(68.2) | χ2=4.617 | 0.032 |
变量 | β值 | s | Wald χ2值 | P值 | HR(95%CI)值 |
---|---|---|---|---|---|
血糖控制不良 | 1.025 | 0.407 | 6.355 | 0.012 | 2.787(1.256~6.183) |
吸烟 | -0.432 | 0.344 | 1.570 | 0.210 | 0.649(0.331~1.276) |
饮酒 | 0.770 | 0.346 | 4.959 | 0.026 | 2.159(1.097~4.251) |
中/重体力活动 | -0.455 | 0.344 | 1.743 | 0.187 | 0.635(0.323~1.246) |
使用保肝药情况 | —0.432 | 0.405 | 1.140 | 0.286 | 0.649(0.294~1.435) |
消瘦(体质量指数<18.5) | 1.032 | 0.359 | 8.294 | 0.004 | 2.808(1.391~5.670) |
贫血 | 0.420 | 0.305 | 1.902 | 0.168 | 1.522(0.838~2.765) |
膳食多样性不足 | 1.163 | 0.432 | 7.244 | 0.007 | 3.199(1.372~7.459) |
[1] |
国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 国家代谢性疾病临床医学研究中心, 等. 结核病与糖尿病共病的治疗管理专家共识. 中国防痨杂志, 2021, 43(1):12-22. doi: 10.3969/j.issn.1000-6621.2021.01.004.
doi: 10.3969/j.issn.1000-6621.2021.01.004 |
[2] |
Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global Brevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2.3 million patients with tuberculosis. Lancet Glob Health, 2019, 7(4):e448-e460. doi: 10.1016/S2214-109X(18)30487=X.
doi: 10.1016/S2214-109X(18)30487=X URL |
[3] |
Al-Rifai RH, Pearson F, Critchley JA, et al. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One, 2017, 12(11):e0187967. doi: 10.1371/journal.pone.0187967.
doi: 10.1371/journal.pone.0187967 |
[4] |
Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, 2018, 138:271-281. doi: 10.1016/j.diabres.2018.02.023.
doi: 10.1016/j.diabres.2018.02.023 URL |
[5] |
Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005, 112(17):2735-2752. doi: 10.1161/CIRCULATIONAHA.105.169404.
doi: 10.1161/CIRCULATIONAHA.105.169404 pmid: 16157765 |
[6] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版). 中国实用内科杂志, 2018, 38(4):292-344. doi: 10.19538/j.nk2018040108.
doi: 10.19538/j.nk2018040108 |
[7] | 卫生部疾病预防控制局, 卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南(2008年版). 北京: 中国协和医科大学出版社, 2009: 7. |
[8] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[9] |
中华医学会结核病学分会. 抗结核药物性肝损伤诊治指南(2019版). 中华结核和呼吸杂志, 2019, 42(5):343-356. doi: 10.3760/cma.j.issn.1001-0939.2019.05.007.
doi: 10.3760/cma.j.issn.1001-0939.2019.05.007 |
[10] |
沈嘉, 陈超刚, 张敬聪, 等. 糖尿病前期患者膳食多样化评分与糖尿病发病的关联分析. 中国食物与营养, 2018, 24(4):71-75. doi: 10.3969/j.issn.1006-9577.2018.04.016.
doi: 10.3969/j.issn.1006-9577.2018.04.016 |
[11] | 中国营养学会. 中国肥胖预防和控制蓝皮书. 北京: 北京大学医学出版社, 2019. |
[12] |
Lee PH, Fu H, Lai TC, et al. Glycemic Control and the Risk of Tuberculosis: A Cohort Study. PLoS Medicine, 2016, 13(8):e1002072. doi: 10.1371/journal.pmed.1002072.
doi: 10.1371/journal.pmed.1002072 |
[13] | 葛均波, 徐永健. 内科学. 8版. 北京: 人民卫生出版社, 2013. |
[14] |
诸骏仁, 高润霖, 赵水平, 等. 中国成人血脂异常防治指南(2016年修订版). 中华健康管理学杂志, 2017, 11(1):7-28. doi: 10.3760/cma.j.issn.1674-0815.2017.01.003.
doi: 10.3760/cma.j.issn.1674-0815.2017.01.003 |
[15] |
Wang P, Pradhan K, Zhong XB, et al. Isoniazid metabolism and hepatotoxicity. Acta Pharm Sin B, 2016, 6(5):384-392. doi: 10.1016/j.apsb.2016.07.014.
doi: 10.1016/j.apsb.2016.07.014 URL |
[16] |
Ahadpour M, Eskandar MR, Mashayekhi V, et al. Mitochondrial oxidative stress and dysfunction induced by isoniazid: Study on isolated rat liver and brain mitochondria. Drug Chem Toxicol, 2016, 39(2):224-232. doi: 10.3109/01480545.2015.1092039.
doi: 10.3109/01480545.2015.1092039 pmid: 26461142 |
[17] |
Zhang T, Ikejima T, Li L, et al. Impairment of Mitochondrial Biogenesis and Dynamics Involved in Isoniazid-Induced Apoptosis of HepG2 Cells Was Alleviated by p38 MAPK Pathway. Front Pharmacol, 2017, 8:753. doi: 10.3389/fphar.2017.00753.
doi: 10.3389/fphar.2017.00753 URL |
[18] |
Zhang TG, Ikejima T, Hayashi T, et al. AMPK activator acadesine fails to alleviate isoniazid-caused mitochondrial instability in HepG2 cells. J Appl Toxicol, 2017, 37:1219-1224. doi: 10.1002/jat.3483.
doi: 10.1002/jat.3483 URL |
[19] |
Liu X, Zhao M, Mi J, et al. Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats. Molecules, 2017, 22(4):524. doi: 10.3390/molecules22040524.
doi: 10.3390/molecules22040524 URL |
[20] |
Zhang T, Du J, Yin X, et al. Adverse Events in Treating Smear-Positive Tuberculosis Patients in China. Int J Environ Res Public Health, 2016, 13(1):86. doi: 10.3390/ijerph13010086.
doi: 10.3390/ijerph13010086 URL |
[21] |
吴玉华, 武谦虎. 抗结核药致肝损害1949例文献分析. 西北药学杂志, 2015, 30(6):750-753. doi: 10.3969/j.issn.1004-2407.2015.06.028.
doi: 10.3969/j.issn.1004-2407.2015.06.028 |
[22] |
候清涛, 李芸, 李舍予, 等. 全球糖尿病疾病负担现状. 中国糖尿病杂志, 2016, 24(1):92-96. doi: 10.3969/j.issn.1006-6187.2016.01.023.
doi: 10.3969/j.issn.1006-6187.2016.01.023 |
[23] |
Singanayagam A, Sridhar S, Dhariwal J, et al. A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med, 2012, 185(6):653-659. doi: 10.1164/rccm.201105-0850OC.
doi: 10.1164/rccm.201105-0850OC URL |
[24] |
Martinez L, Zhu L, Castellanos ME, et al. Glycemic Control and the Prevalence of Tuberculosis Infection: A Population-based Observational Study. Clin Infect Dis, 2017, 65(12):2060-2068. doi: 10.1093/cid/cix632.
doi: 10.1093/cid/cix632 URL |
[25] |
李永红, 李红恩, 雷世鑫, 等. 抗结核药致中国人群药物性肝损伤危险因素的Meta分析. 中国抗生素杂志, 2021, 46(6):628-633. doi: 10.13461/j.cnki.cja.007056.
doi: 10.13461/j.cnki.cja.007056 |
[26] |
吴启文, 姚叶萍, 赖小丽. 92例抗结核药物致肺结核患者肝损伤的临床特征分析. 中国新药与临床杂志, 2020, 39(7):417-420. doi: 10.14109/j.cnki.xyylc.2020.07.09.
doi: 10.14109/j.cnki.xyylc.2020.07.09 |
[27] |
何涛, 汪峰, 唐武. 抗结核药致药物性肝损伤危险因素的logistic回归分析. 中国药房, 2016, 27(12):1626-1628. doi: 10.6039/j.issn.1001-0408.2016.12.15.
doi: 10.6039/j.issn.1001-0408.2016.12.15 |
[28] |
杨学敏, 沈宝荣, 刘鹏园, 等. 抗结核药致药物性肝损伤危险因素的Logistic回归分析. 中国医院药学杂志, 2019, 39(1):67-71. doi: 10.13286/j.cnki.chinhosppharmacyj.2019.01.15.
doi: 10.13286/j.cnki.chinhosppharmacyj.2019.01.15 |
[29] |
程亮, 陈惠芬, 高爱霞, 等. 无锡地区一线口服抗结核药物所致药物性肝损伤多因素分析. 临床肺科杂志, 2018, 23(7):1172-1174. doi: 10.3969/j.issn.1009-6663.2018.07.003.
doi: 10.3969/j.issn.1009-6663.2018.07.003 |
[30] |
赵红, 程澄, 谢雯. 抗结核药物致肝损伤的发病机制. 中国肝脏病杂志(电子版), 2015, 7(4):11-13. doi: 10.3969/j.issn.1674-7380.2015.04.005.
doi: 10.3969/j.issn.1674-7380.2015.04.005 |
[31] |
Ishikawa M, Moriya S, Yokoyama T. Relationship between diet-related indicators and overweight and obesity in older adults in rural Japan. J Nutr Health Aging, 2017, 21(7):759-765. doi: 10.1007/s12603-016-0807-x.
doi: 10.1007/s12603-016-0807-x pmid: 28717805 |
[32] |
Sun L, Luo C, Long J, et al. Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion, 2006, 6(3):136-142. doi: 10.1016/j.mito.2006.04.003.
doi: 10.1016/j.mito.2006.04.003 URL |
[1] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[2] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[3] | Zhang Guoqin, Qu Ting, Meng Qinglin, Zhou Lin, Liu Eryong. Implementation update of strategy for the control of tuberculosis and HIV/AIDS co-infection in China [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 12-17. |
[4] | Huang Tao, Jian Huiyong, Wang Xinqi, Liu Nianqiang, Yipar Aihaiti, Wang Mingzhe, Jiayinati Jingesi, Wang Senlu. Analysis of influencing factors of treatment outcomes in patients with pulmonary tuberculosis complicated with diabetes mellitus in Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1083-1088. |
[5] | Yang Liangzi, Zhang Peize, Lu Shuihua. Interpretation of World Health Organization’s Co-administration of Treatment for Drug-resistant Tuberculosis and Hepatitis C: 2024 Update [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 874-876. |
[6] | Liu Ling, Zeng Yi, Wang Jin, Liu Xiaoling, Liu Yan, Lin Feishen, Guo Jing. Construction and evaluation of a model for predicting malnutrition in patients with pulmonary tuberculosis and diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 903-909. |
[7] | Cai Qinghe, Fu Hui, Chen Ruiming, Fan Youming, Yang Qingwei. Analysis of the clinical characteristics and influencing factors of pulmonary tuberculosis patients with diabetes mellitus in Shantou City from 2016 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 926-934. |
[8] | Jiang Bijia, Chen Cheng, Zhou Jinyi, Zhu Limei, Su Jian, Lu Wei. Analysis of tuberculosis incidence and influencing factors in type 2 diabetic patients in community [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 951-957. |
[9] | Chai Dongyu, Qin Shuyi, Zhang Ronghua, Zou Nannan, Wang Xin. Analysis of risk factors for viral pneumonia combined with invasive pulmonary mycosis [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 750-755. |
[10] | Fu Keyan, Zhu Bangzheng, Ye Jian. Research progress on interstitial lung disease combined with Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 823-829. |
[11] | Liu Guizhen, Deng Guofang. Interpretation of Evidence and research gaps identified during development of policy guidelines for tuberculosis (Second edition): tuberculosis related comorbidity [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 618-624. |
[12] | Li Yao, Fang Zhe, Luo Danlin, Hu Yanmei, Tang Mi, Tang Zhigang, Wen Xinmin, Zhang Yong, Yao Bibo, Wang Qi, Yi Hengzhong. Clinical characteristics and prognosis of patients with novel coronavirus infection complicated with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 687-698. |
[13] | Geng Junling, Zhang Yinan, Pan Hongqiu. Establishment and validation of a risk prediction model for drug-induced liver injury in patients with tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 699-706. |
[14] | Yang Rui, Li Ling, Chen Jinou, Xu Lin. Analysis of influencing factors of anti-tuberculosis treatment effect for pulmonary tuberculosis patients complicated with diabetes in Yunnan Province from 2017 to 2021 [J]. Chinese Journal of Antituberculosis, 2024, 46(5): 519-524. |
[15] | Liu Meijun, Li Feng. Current situation and research progress of co-infection of HIV/AIDS and subclinical tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(5): 596-600. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||